 Travis Nemkov
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 43 | 2024 | 591 | 6.130 |
Why?
| | Metabolomics | 31 | 2024 | 527 | 3.670 |
Why?
| | Metabolome | 23 | 2023 | 283 | 2.900 |
Why?
| | Blood Preservation | 23 | 2024 | 263 | 2.670 |
Why?
| | Blood Donors | 8 | 2024 | 89 | 2.140 |
Why?
| | Mass Spectrometry | 11 | 2019 | 633 | 1.420 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 123 | 1.380 |
Why?
| | Erythrocyte Transfusion | 11 | 2023 | 186 | 1.300 |
Why?
| | Glycolysis | 18 | 2023 | 227 | 1.100 |
Why?
| | Hypoxia | 10 | 2023 | 957 | 1.060 |
Why?
| | Amino Acids | 10 | 2023 | 448 | 1.040 |
Why?
| | Energy Metabolism | 10 | 2021 | 729 | 0.960 |
Why?
| | Oxidative Stress | 12 | 2022 | 1084 | 0.960 |
Why?
| | Hemolysis | 4 | 2024 | 146 | 0.950 |
Why?
| | Membrane Lipids | 2 | 2021 | 87 | 0.870 |
Why?
| | Proteomics | 7 | 2022 | 843 | 0.870 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 193 | 0.840 |
Why?
| | Athletic Performance | 1 | 2023 | 54 | 0.820 |
Why?
| | Erythroblasts | 1 | 2022 | 12 | 0.820 |
Why?
| | Drosophila Proteins | 5 | 2024 | 163 | 0.790 |
Why?
| | Lipid Metabolism | 6 | 2021 | 446 | 0.780 |
Why?
| | Purines | 4 | 2022 | 159 | 0.750 |
Why?
| | Animals | 59 | 2024 | 31762 | 0.710 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.700 |
Why?
| | Leukemia | 2 | 2019 | 210 | 0.670 |
Why?
| | Physical Exertion | 1 | 2021 | 211 | 0.670 |
Why?
| | Fatty Acids | 7 | 2024 | 382 | 0.660 |
Why?
| | Prescription Drugs | 1 | 2021 | 116 | 0.650 |
Why?
| | Carbon | 2 | 2017 | 157 | 0.640 |
Why?
| | Drosophila melanogaster | 6 | 2024 | 191 | 0.630 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 536 | 0.620 |
Why?
| | Cell Death | 1 | 2020 | 322 | 0.620 |
Why?
| | Lymph | 2 | 2016 | 40 | 0.620 |
Why?
| | Hypoxanthine | 1 | 2017 | 9 | 0.590 |
Why?
| | Mice | 31 | 2023 | 14916 | 0.580 |
Why?
| | Muscle, Skeletal | 8 | 2022 | 1472 | 0.580 |
Why?
| | Bone Marrow | 1 | 2018 | 244 | 0.570 |
Why?
| | Iron | 1 | 2018 | 234 | 0.560 |
Why?
| | Humans | 88 | 2024 | 114757 | 0.550 |
Why?
| | Exercise | 3 | 2023 | 1644 | 0.530 |
Why?
| | Nitrogen | 1 | 2017 | 145 | 0.530 |
Why?
| | Altitude Sickness | 5 | 2018 | 172 | 0.520 |
Why?
| | Transfusion Medicine | 1 | 2015 | 8 | 0.520 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 927 | 0.520 |
Why?
| | Kynurenine | 5 | 2024 | 80 | 0.500 |
Why?
| | Lipids | 1 | 2019 | 582 | 0.490 |
Why?
| | Hemoglobins | 4 | 2022 | 314 | 0.480 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 32 | 0.460 |
Why?
| | Aging | 7 | 2021 | 1620 | 0.460 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.440 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4710 | 0.420 |
Why?
| | Taste Buds | 1 | 2015 | 209 | 0.410 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 334 | 0.410 |
Why?
| | Hemorrhage | 2 | 2022 | 618 | 0.410 |
Why?
| | Inflammation | 6 | 2021 | 2481 | 0.400 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 472 | 0.390 |
Why?
| | Healthy Volunteers | 7 | 2021 | 197 | 0.390 |
Why?
| | Oxygen | 5 | 2020 | 853 | 0.390 |
Why?
| | Anemia | 2 | 2023 | 144 | 0.370 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 642 | 0.370 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 483 | 0.350 |
Why?
| | Male | 41 | 2023 | 55579 | 0.350 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 172 | 0.350 |
Why?
| | Flavones | 2 | 2019 | 10 | 0.340 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2209 | 0.340 |
Why?
| | Altitude | 4 | 2023 | 433 | 0.340 |
Why?
| | Sphingosine | 3 | 2023 | 33 | 0.330 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 119 | 0.330 |
Why?
| | Blood Banks | 3 | 2019 | 40 | 0.320 |
Why?
| | Exercise Tolerance | 2 | 2023 | 213 | 0.320 |
Why?
| | Lysophospholipids | 3 | 2023 | 65 | 0.320 |
Why?
| | Biomarkers | 8 | 2023 | 3416 | 0.310 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 13 | 0.310 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 344 | 0.300 |
Why?
| | Thrombosis | 2 | 2022 | 297 | 0.300 |
Why?
| | Hematopoietic Stem Cells | 2 | 2023 | 345 | 0.300 |
Why?
| | Proteome | 4 | 2020 | 339 | 0.290 |
Why?
| | Acclimatization | 3 | 2018 | 150 | 0.290 |
Why?
| | Hematopoiesis | 2 | 2018 | 172 | 0.280 |
Why?
| | Female | 39 | 2023 | 59507 | 0.280 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 43 | 0.280 |
Why?
| | Wounds and Injuries | 3 | 2020 | 723 | 0.270 |
Why?
| | Adult | 23 | 2023 | 30548 | 0.270 |
Why?
| | Mammals | 3 | 2023 | 245 | 0.270 |
Why?
| | Tryptophan | 4 | 2021 | 135 | 0.270 |
Why?
| | Sciuridae | 2 | 2019 | 142 | 0.270 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 49 | 0.270 |
Why?
| | Plasma | 3 | 2017 | 210 | 0.270 |
Why?
| | Carnitine | 3 | 2021 | 62 | 0.270 |
Why?
| | Insulin Resistance | 3 | 2021 | 1072 | 0.260 |
Why?
| | Isotope Labeling | 2 | 2017 | 69 | 0.260 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 450 | 0.260 |
Why?
| | Rats | 7 | 2021 | 4943 | 0.260 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 141 | 0.260 |
Why?
| | Collagen | 2 | 2020 | 415 | 0.260 |
Why?
| | Drosophila | 2 | 2024 | 133 | 0.260 |
Why?
| | Erythropoiesis | 2 | 2023 | 34 | 0.260 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 340 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 332 | 0.250 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 2725 | 0.250 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 463 | 0.240 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 48 | 0.240 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 158 | 0.240 |
Why?
| | Polyamines | 2 | 2022 | 35 | 0.240 |
Why?
| | Interleukin-1 | 2 | 2021 | 966 | 0.240 |
Why?
| | Blood Platelets | 2 | 2019 | 351 | 0.240 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 93 | 0.230 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.230 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 168 | 0.230 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 20 | 0.230 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 12 | 0.230 |
Why?
| | Blood Group Antigens | 1 | 2023 | 14 | 0.230 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.230 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1013 | 0.220 |
Why?
| | Oxygen Consumption | 3 | 2023 | 588 | 0.220 |
Why?
| | Glutamine | 3 | 2019 | 91 | 0.220 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 24 | 0.220 |
Why?
| | Obesity | 5 | 2021 | 2513 | 0.220 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 41 | 0.220 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 156 | 0.220 |
Why?
| | Succinates | 1 | 2023 | 18 | 0.220 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 63 | 0.210 |
Why?
| | Lactates | 1 | 2023 | 79 | 0.210 |
Why?
| | Liver | 3 | 2019 | 1631 | 0.210 |
Why?
| | Furin | 1 | 2022 | 12 | 0.210 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 29 | 0.210 |
Why?
| | Equidae | 1 | 2022 | 4 | 0.210 |
Why?
| | src-Family Kinases | 1 | 2023 | 88 | 0.210 |
Why?
| | Glucose | 3 | 2017 | 897 | 0.200 |
Why?
| | Bicycling | 1 | 2023 | 85 | 0.200 |
Why?
| | Histiocytosis | 1 | 2022 | 8 | 0.200 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 175 | 0.200 |
Why?
| | Sulfonamides | 3 | 2020 | 445 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.200 |
Why?
| | Mice, Knockout | 4 | 2023 | 2582 | 0.200 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 5 | 0.200 |
Why?
| | Protein Domains | 1 | 2022 | 207 | 0.190 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 83 | 0.190 |
Why?
| | Resistance Training | 1 | 2023 | 113 | 0.190 |
Why?
| | Cholesterol | 2 | 2022 | 368 | 0.190 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 214 | 0.190 |
Why?
| | Sphingolipids | 2 | 2021 | 57 | 0.190 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.190 |
Why?
| | Ranitidine | 1 | 2021 | 13 | 0.190 |
Why?
| | Cannabidiol | 1 | 2022 | 60 | 0.190 |
Why?
| | Erythrocyte Count | 1 | 2021 | 19 | 0.190 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 176 | 0.190 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 229 | 0.190 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 53 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 139 | 0.180 |
Why?
| | Auditory Pathways | 1 | 2021 | 53 | 0.180 |
Why?
| | Syndecan-1 | 1 | 2020 | 27 | 0.180 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 29 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 168 | 0.180 |
Why?
| | Machine Learning | 2 | 2021 | 318 | 0.180 |
Why?
| | Macrophages | 4 | 2022 | 1261 | 0.180 |
Why?
| | Cell Plasticity | 1 | 2021 | 23 | 0.180 |
Why?
| | Benzothiazoles | 2 | 2017 | 33 | 0.180 |
Why?
| | Cannabinoids | 1 | 2022 | 115 | 0.180 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 80 | 0.180 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 95 | 0.180 |
Why?
| | Stromal Cells | 1 | 2020 | 96 | 0.180 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 78 | 0.180 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 84 | 0.180 |
Why?
| | Osmotic Pressure | 1 | 2020 | 28 | 0.170 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 84 | 0.170 |
Why?
| | Macrophage Activation | 1 | 2021 | 164 | 0.170 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 348 | 0.170 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 263 | 0.170 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 20 | 0.170 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.170 |
Why?
| | Shock | 1 | 2020 | 75 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 193 | 0.170 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 173 | 0.170 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.170 |
Why?
| | Hibernation | 2 | 2019 | 72 | 0.170 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 22 | 0.170 |
Why?
| | Parabiosis | 1 | 2019 | 12 | 0.170 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 287 | 0.170 |
Why?
| | Circadian Clocks | 1 | 2019 | 42 | 0.160 |
Why?
| | Mitochondria | 3 | 2019 | 751 | 0.160 |
Why?
| | Transcriptome | 2 | 2021 | 727 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 399 | 0.160 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.160 |
Why?
| | Homeostasis | 2 | 2022 | 575 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2020 | 72 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1728 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 433 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2020 | 136 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 77 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 31 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 184 | 0.150 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 172 | 0.150 |
Why?
| | Stem Cell Niche | 1 | 2018 | 42 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 202 | 0.150 |
Why?
| | Young Adult | 8 | 2021 | 10463 | 0.150 |
Why?
| | Arousal | 1 | 2019 | 152 | 0.150 |
Why?
| | Signal Transduction | 7 | 2022 | 4522 | 0.150 |
Why?
| | Proteostasis | 1 | 2018 | 20 | 0.150 |
Why?
| | Time Factors | 9 | 2018 | 6124 | 0.150 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.150 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 347 | 0.150 |
Why?
| | Neoplasms | 2 | 2022 | 2105 | 0.150 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 14 | 0.150 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 13 | 0.150 |
Why?
| | Cryopreservation | 1 | 2018 | 92 | 0.150 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 230 | 0.150 |
Why?
| | Calcium | 2 | 2022 | 1103 | 0.150 |
Why?
| | Diglycerides | 1 | 2018 | 54 | 0.150 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
| | Glutaminase | 1 | 2017 | 10 | 0.150 |
Why?
| | Nicotine | 1 | 2020 | 265 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
| | Breast Neoplasms | 2 | 2020 | 1868 | 0.140 |
Why?
| | Resuscitation | 2 | 2018 | 247 | 0.140 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
| | Nitriles | 1 | 2018 | 151 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 173 | 0.140 |
Why?
| | Limit of Detection | 1 | 2017 | 53 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 13 | 0.140 |
Why?
| | Body Fluids | 1 | 2017 | 58 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 284 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 144 | 0.140 |
Why?
| | Citric Acid | 1 | 2016 | 30 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.140 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 63 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 115 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2020 | 675 | 0.140 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2016 | 37 | 0.140 |
Why?
| | Folic Acid | 1 | 2017 | 161 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 254 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 53 | 0.130 |
Why?
| | Lactic Acid | 4 | 2021 | 275 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 486 | 0.130 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 300 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 312 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 413 | 0.130 |
Why?
| | Bacteria | 1 | 2022 | 726 | 0.130 |
Why?
| | Models, Biological | 2 | 2021 | 1630 | 0.130 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 536 | 0.130 |
Why?
| | Brain Death | 1 | 2016 | 31 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 71 | 0.130 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 66 | 0.130 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 9 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 138 | 0.130 |
Why?
| | Middle Aged | 9 | 2021 | 26757 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 530 | 0.130 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.130 |
Why?
| | Pandemics | 2 | 2020 | 1319 | 0.130 |
Why?
| | Vasodilation | 1 | 2018 | 415 | 0.130 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2021 | 723 | 0.130 |
Why?
| | Biochemistry | 1 | 2015 | 40 | 0.130 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.130 |
Why?
| | Fluid Therapy | 1 | 2016 | 122 | 0.130 |
Why?
| | Acidosis | 1 | 2016 | 87 | 0.130 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 39 | 0.130 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 133 | 0.120 |
Why?
| | Adipose Tissue | 2 | 2017 | 539 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 245 | 0.120 |
Why?
| | Platelet Transfusion | 1 | 2015 | 64 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 84 | 0.120 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 189 | 0.120 |
Why?
| | Extinction, Biological | 1 | 2015 | 29 | 0.120 |
Why?
| | Blood Volume | 1 | 2015 | 59 | 0.120 |
Why?
| | Sulfur | 3 | 2022 | 46 | 0.120 |
Why?
| | Citrates | 1 | 2014 | 43 | 0.120 |
Why?
| | Cells, Cultured | 5 | 2021 | 3890 | 0.120 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 39 | 0.120 |
Why?
| | Linear Models | 1 | 2017 | 770 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 145 | 0.120 |
Why?
| | Health Status | 1 | 2019 | 723 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 589 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 216 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 843 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1134 | 0.120 |
Why?
| | Sodium Chloride | 1 | 2014 | 136 | 0.110 |
Why?
| | Methionine | 3 | 2020 | 144 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 158 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2097 | 0.110 |
Why?
| | Fetal Development | 1 | 2016 | 246 | 0.110 |
Why?
| | Proteolysis | 3 | 2020 | 143 | 0.110 |
Why?
| | Dietary Supplements | 1 | 2017 | 460 | 0.110 |
Why?
| | Prognosis | 1 | 2021 | 3334 | 0.110 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 1895 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 709 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 385 | 0.110 |
Why?
| | Peptide Fragments | 1 | 2017 | 668 | 0.110 |
Why?
| | Blood Transfusion | 3 | 2022 | 276 | 0.110 |
Why?
| | Adenine | 1 | 2014 | 219 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 621 | 0.110 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 343 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 452 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2017 | 592 | 0.110 |
Why?
| | Aged | 5 | 2023 | 19094 | 0.110 |
Why?
| | Diet | 1 | 2020 | 1080 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 447 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2016 | 507 | 0.100 |
Why?
| | Larva | 3 | 2020 | 194 | 0.100 |
Why?
| | Muscles | 2 | 2023 | 320 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 601 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3542 | 0.100 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 529 | 0.100 |
Why?
| | Microbiota | 1 | 2018 | 648 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 706 | 0.090 |
Why?
| | Insulin | 2 | 2021 | 2079 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 955 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 795 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 561 | 0.090 |
Why?
| | Cell Proliferation | 4 | 2019 | 2196 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 732 | 0.090 |
Why?
| | Cell Line | 3 | 2022 | 2639 | 0.090 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 43 | 0.090 |
Why?
| | Phenotype | 4 | 2020 | 2812 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2763 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 921 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 181 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1951 | 0.080 |
Why?
| | Phosphorylation | 3 | 2018 | 1571 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1361 | 0.080 |
Why?
| | Brain | 2 | 2021 | 2374 | 0.080 |
Why?
| | Diet, High-Fat | 2 | 2019 | 225 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 151 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 50 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 640 | 0.070 |
Why?
| | Neurons | 1 | 2015 | 1281 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1147 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 252 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 521 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 192 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 787 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 54 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 35 | 0.070 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 347 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2369 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2018 | 430 | 0.070 |
Why?
| | Mice, Nude | 2 | 2018 | 635 | 0.070 |
Why?
| | Adolescent | 2 | 2021 | 17808 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1040 | 0.060 |
Why?
| | Swine | 2 | 2018 | 700 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 38 | 0.060 |
Why?
| | Arginine | 2 | 2016 | 236 | 0.060 |
Why?
| | Blood Glucose | 3 | 2020 | 1821 | 0.060 |
Why?
| | Cold Temperature | 2 | 2016 | 128 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1021 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 681 | 0.060 |
Why?
| | Glutathione | 2 | 2016 | 300 | 0.060 |
Why?
| | RNA Interference | 2 | 2017 | 437 | 0.060 |
Why?
| | Prospective Studies | 3 | 2021 | 6217 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 4 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 812 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| | Mutation | 3 | 2022 | 3350 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 543 | 0.060 |
Why?
| | Respiratory Therapy | 1 | 2023 | 19 | 0.060 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 35 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 46 | 0.050 |
Why?
| | Heme | 1 | 2023 | 52 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 95 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 126 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 49 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 66 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 188 | 0.050 |
Why?
| | Horses | 1 | 2022 | 96 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 867 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2557 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 139 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 1843 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2023 | 511 | 0.050 |
Why?
| | Quality of Life | 2 | 2023 | 2358 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 4901 | 0.050 |
Why?
| | Dogs | 1 | 2022 | 334 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 799 | 0.050 |
Why?
| | Oncogenes | 1 | 2021 | 107 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2022 | 217 | 0.050 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 6 | 0.050 |
Why?
| | Candidiasis | 1 | 2021 | 52 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2021 | 78 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| | Immunity | 1 | 2021 | 121 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 105 | 0.050 |
Why?
| | Muscle Strength | 1 | 2023 | 270 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2023 | 299 | 0.050 |
Why?
| | Point Mutation | 1 | 2021 | 216 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 612 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 84 | 0.050 |
Why?
| | Cystine | 1 | 2020 | 14 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 201 | 0.040 |
Why?
| | Genome | 1 | 2022 | 272 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 137 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 4 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 90 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 50 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 794 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 64 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 44 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 356 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 193 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 30 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 202 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 176 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 131 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1662 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 6 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 139 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 68 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 180 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 28 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 151 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 424 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4409 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 912 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 44 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 84 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 503 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 183 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 62 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 574 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 476 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 208 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2321 | 0.040 |
Why?
| | Formic Acid Esters | 1 | 2017 | 4 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 10 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 15 | 0.040 |
Why?
| | Biological Transport | 1 | 2018 | 372 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 213 | 0.040 |
Why?
| | Metabolism | 1 | 2017 | 35 | 0.040 |
Why?
| | Azacitidine | 1 | 2018 | 129 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2017 | 71 | 0.040 |
Why?
| | Pyrroles | 1 | 2018 | 183 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1197 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 431 | 0.040 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 34 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 208 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 140 | 0.040 |
Why?
| | Blood Proteins | 1 | 2019 | 232 | 0.040 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| | Fluorenes | 1 | 2017 | 38 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 335 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| | Anaerobiosis | 1 | 2017 | 49 | 0.040 |
Why?
| | Femoral Fractures | 1 | 2017 | 67 | 0.040 |
Why?
| | Cystathionine | 1 | 2016 | 25 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 75 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1420 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 55 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 48 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 112 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 912 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 86 | 0.030 |
Why?
| | Erythrocyte Aging | 1 | 2016 | 6 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2022 | 739 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 144 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 28 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 6 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | NADP | 1 | 2016 | 43 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 239 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 40 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 43 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 93 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 219 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 838 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 134 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 76 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 470 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1013 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 210 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 51 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 306 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 59 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 85 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 70 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 572 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 130 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 208 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 546 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 261 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 271 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 227 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5525 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 211 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 234 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 171 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1378 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1226 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 271 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 370 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1163 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 140 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 181 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 125 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1528 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 185 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 213 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 379 | 0.030 |
Why?
| | Europe | 1 | 2015 | 336 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 130 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 194 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 242 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 91 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1086 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 585 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1435 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 292 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 320 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 460 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1022 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 870 | 0.030 |
Why?
| | Running | 1 | 2017 | 207 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 450 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 325 | 0.030 |
Why?
| | Skull | 1 | 2015 | 119 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 544 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 281 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 445 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 1958 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2539 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 946 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1316 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 954 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1233 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 528 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 812 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1218 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3005 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 501 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 388 | 0.030 |
Why?
| | Athletes | 1 | 2016 | 328 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 298 | 0.030 |
Why?
| | Fetus | 1 | 2016 | 699 | 0.030 |
Why?
| | NF-kappa B | 1 | 2015 | 636 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 1897 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1988 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2791 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6350 | 0.020 |
Why?
| | United States | 1 | 2015 | 12176 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|